CompletedNCT00129272
Bupropion with or without behavioral support for young smokers
About this title
Effectiveness of Bupropion for Treating Nicotine Dependence in Young People
Read the official source — NCT00129272Medication studyAges 12–25United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 12 years to 25 years.
- Listed locations
- DallasSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateMay 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 172
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 12 Years to 25 Years
- Official registry ID
- NCT00129272
- Official title
Show the full official title
Stress Response and Smoking Cessation in Depressed Youth
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Dallas
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.
Did this study involve medication?
Yes. The study involved medication, including Bupropion-SR.
Who was this study for?
Listed age limits: 12 years to 25 years.
